www.fdanews.com/articles/179706-protagen-ag-debuts-navigaid-assay
Protagen AG Debuts NavigAID Assay
December 14, 2016
Germany-based Protagen AG launched NavigAID SSc, a stratification assay designed to assist in developing drugs for systemic sclerosis.
This assay enables segregation of patient subgroups by serum amount biomarkers.
NavigAID SSc is the most recent addition to the Protagen NavigAID portfolio. — Cynthia Jessup